| Literature DB >> 33986308 |
Estefanía Conde-Blanco1, Saül Pascual-Diaz2, Mar Carreño3, Emma Muñoz-Moreno2, José Carlos Pariente2, Teresa Boget4, Isabel Manzanares3, Antonio Donaire3, María Centeno3, Francesc Graus5, Nuria Bargalló2,6.
Abstract
Glutamic acid decarboxylase 65 antibodies (anti-GAD65) have been found in patients with late-onset chronic temporal lobe epilepsy (TLE). No prior neuroimaging studies have addressed how they affect hippocampal volume and shape and how they relate to cognitive abnormalities. We aimed to investigate both brain structure and function in patients with isolated TLE and high anti-GAD65 levels (RIA ≥ 2000 U/ml) compared to 8 non-immune mesial TLE (niTLE) and 8 healthy controls (HC). Hippocampal subfield volume properties were correlated with the duration of the disease and cognitive test scores. The affected hippocampus of GAD-TLE patients showed no volume changes to matched HC whereas niTLE volumes were significantly smaller. Epilepsy duration in GAD-TLE patients correlated negatively with volumes in the presubiculum, subiculum, CA1, CA2-3, CA4, molecular layer and granule cell-molecular layer of the dentate nucleus. We found differences by advanced vertex-wise shape analysis in the anterior hippocampus of the left GAD-TLE compared to HC whereas left niTLE showed bilateral posterior hippocampus deformation. Verbal deficits were similar in GAD-TLE and niTLE but did not correlate to volume changes. These data might suggest a distinct expression of hippocampal structural and functional abnormalities based on the immune response.Entities:
Year: 2021 PMID: 33986308 PMCID: PMC8119423 DOI: 10.1038/s41598-021-89010-z
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Demographic, clinical and MRI features of the three groups evaluated.
| Characteristics | GAD-TLE (8) | niTLE (8) | HC (8) |
|---|---|---|---|
| Median age at MRI (IQR) (years) | 37.3 (5.9) | 37.1 (30) | 34 (8.5) |
| Median age at onset (IQR) (years) | 29 (5.5) | 9 (11.5) | N/A |
| Duration of Epilepsy Me (IQR) | 7.9 (8.6) | 16.9 (24.7) | N/A |
| Female | 6 (75) | 7 (87.5) | 5 (62.5) |
| Male | 2 (25) | 1 (12.5) | 3 (37.5) |
| Autoimmune comorbidities n (%) | 6 (54.5) | 0 | 0 |
| Primary education | 1 (12.5) | 4 (50%) | N/A |
| Secondary education | 1 (12.5) | 2 (25%) | |
| University education | 6 (75) | 2(25%) | |
| Right dominance | 8 (100) | 7 (87.5) | 8 (100) |
| 3 (37.5) | 8 (100) | ||
| Right | 1 | 1 | N/A |
| Left | 0 | 7 | |
| Bilateral | 2 | 0 | |
| Unilateral | |||
| Right | 2 (25) | 2 (25) | |
| Left | 4 (50) | 6 (75) | N/A |
| Bilateral | 2(25) | 0 (0) | |
| Daily | 3 (37.5) | 0 | N/A |
| Weekly | 2 (25) | 1 (12.5) | |
| Monthly | 3 (37.5) | 7 (87.5) | |
| FAS and FIAS | 7 (87.5) | 8 (100) | N/A |
| FBTCS | 1 (12.5) | 0 (0) | |
| Present ASM median (IQR) | 3 (1) | 3 (2) | N/A |
| Prior ASM median (IQR) | 4.5 (1.5) | 2.5 (1) | N/A |
TLE temporal lobe epilepsy, FAS focal aware seizures, FIAS focal impaired awareness, FBTCS focal to bilateral tonic–clonic seizure, ASM antiseizure medication, Me median, IQR interquartile range, N/A not applicable.
Whole and subfield volumes of the affected and contralateral hippocampus of GAD-TLE patients compared with those of niTLE and HC.
| Hippocampal Subfields | Proportion between (%) | Affected hippocampus (volume, mm3) | Contralateral hippocampus | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Affected/non-affected hippocampus | GAD-TLE (n:10)† [Me, IQR] | niTLE (n:8)† [Me, IQR] | HC (n:16)† [Me, IQR] | Kruskal wallis test ( | Bonferroni post hoc | GADTLE (n:6)†[Me, IQR] | niTLE (n:8)†[Me, IQR] | Bonferroni post hoc | |||||
| GAD65ab | niTLE | GAD65ab vs niTLE | GAD65ab vs HC | niTLE vs HC | GAD65-niTLE | niTLE-HC | |||||||
| Presubiculum | − 8.9 | − 25.2 | 174.4 (85.10) | 146.0 (35.0) | 198.8 (51.1) | 0.003 | NS | NS | < 0.0001* | 191.39 (78.89) | 195.18 (38.5) | NS | NS |
| Parasubiculum | − 7.3 | − 28.3 | 34.0 (12.12) | 30.9 (10.6) | 41.7 (10.2) | 0.02 | NS | NS | 0.016* | 36.7(9.08) | 43.13(8.59) | NS | NS |
| Subiculum | − 8.35 | − 30.6 | 251.1(96.19) | 202.1 (27.0) | 274.3 (49.8) | 0.0004 | 0.004* | NS | < 0.0001* | 273.95 (93.89) | 291.09 (36.05) | NS | NS |
| CA1 | − 11.7 | − 36.9 | 372.9(159.28) | 284.0 (55.8) | 429.8 (58.1) | 0.0006 | 0.002* | NS | < 0.0001* | 422.27 (107.6) | 450.11 (31.86) | NS | NS |
| CA3 | 5.2 | − 33.9 | 142.4 (41.07) | 94.0 (28.7) | 134.5 (28.7) | 0.0013 | 0.001* | NS | 0.001* | 135.45 (44.46) | 142.39 (27.50) | NS | NS |
| CA4 | − 10.4 | − 35.5 | 164.1 (53.47) | 116.6 (18.6) | 170.6 (20.9) | 0.0003 | 0.001* | NS | 0.001* | 183.20(48.35) | 180.9 (12.71) | NS | NS |
| GC-ML-DG | − 13.9 | − 35.3 | 186.6 (59.64) | 134.4 (20.8) | 198.4 (25.3) | 0.0003 | 0.001* | NS | < 0.0001* | 216.73 (61.41) | 207.75 (16.0) | NS | NS |
| HATA | − 6.83 | − 15.5 | 42.1 (10.97) | 34.7 (8.1) | 38.8 (6.4) | NS | NS | NS | NS | 45.22 (14.14) | 41.05 (9.64) | NS | NS |
| Fimbria | − 11.44 | − 17.6 | 49.3 (24.96) | 50.4 (19.4) | 53.7 (12.8) | NS | NS | NS | NS | 55.67(24.87) | 61.14 (13.64) | NS | NS |
| Molecular layer | − 13.88 | − 36.1 | 336.1(113.34) | 253.2 (45.7) | 392.6 (47.5) | 0.0002 | 0.001* | NS | < 0.0001* | 390.27 (101.29) | 396.49 (40.85) | NS | NS |
| Hippocampal fissure | − 3.32 | − 16.5 | 95.9 (26.7) | 80.5 (16.3) | 84.2 (24.1) | NS | NS | NS | NS | 99.24 (37.28) | 96.53 (18.70) | NS | NS |
| Hippocampal tail | − 4.27 | − 30.7 | 375.5 (83.48) | 264.2 (24.9) | 372.5 (41.1) | 0.0011 | 0.002* | NS | < 0.0001* | 392.23 (123.53) | 381.56 (91.66) | NS | NS |
| Whole Hippocampus | − 15.31 | − 35.7 | 2070.70 (682.0) | 1574.1(276.3) | 2292.7 (206.1) | 0.0003 | 0.001* | NS | < 0.0001* | 2445.12 (596.72) | 2446.75 (230.72) | NS | NS |
n number of hippocampus included in the analysis, CA1-2–3-4 Cornu ammonis areas 1,2–3,4, GC-ML-DG granule cells in the molecular layer of the dentate gyrus, HATA hippocampus-amygdala-transition-area. NS non-significant, Me median, IQR interquartile range.
Figure 1Z-scores of hippocampal subfields volume deviation from HC of each subfield in the affected and contralateral hippocampus of GAD-TLE and niTLE (Median; IQR).
Figure 2Asymmetry index: significant asymmetry towards the contralateral hippocampus in GAD-TLE compared to niTLE and HC. *Significant asymmetry in each subfield (Kruskal–Wallis test).
Figure 3Hippocampal subfields and correlation with disease duration. In the plot the dots represent values for each hippocampal subfield and its correlation with epilepsy duration. On GAD-TLE patients we see a strong negative correlation in the represented subfields, while in niTLE volumes appear randomly scattered and therefore show a non-significantly weak or absent correlation. CA1–2–3–4 cornu ammonis areas 1,2–3,4, GC-ML-DG granule cells in the molecular layer of the dentate gyrus, HATA hippocampus-amygdala-transition-area.
Figure 4Shape comparison of the respective ipsilateral and contralateral hippocampus in patients with left GAD-TLE compared to left niTLE and HC. (a) Left hippocampus of niTLE versus HC; (b) left hippocampus of niTLE versus GAD-TLE; (c) left hippocampus of GAD-TLE versus HC; (d) right hippocampus of niTLE versus HC; (e) right hippocampus of niTLE versus GAD-TLE; (f) right hippocampus of GAD-TLE versus HC. Thresholded scale on the right indicates FDR corrected p values of significant shape change–cooler colors indicate lesser significance and warmer colors significant change.